German health care and science group Merck has sealed a deal to bolster its cancer treatment portfolio with a $3.9-billion ...

For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

Merck KGaA agreed to buy SpringWorks Therapeutics Inc., a maker of medicines for cancer and rare diseases, to boost its ...

LIfT BioSciences announces partnership with University of Galway for clinical trial in Ireland ...

While technology may continue to be an excellent investment and repeat its outstanding returns of the past five years, the recent short-term sell-off flags the possibility of a significant slump and ...

German healthcare and materials group Merck KGaA has struck a deal, it said on Monday, to acquire U.S. biotech company ...

The quiet rise of K18—a premium haircare brand with a scientific soul—offers a textbook case of what modern consumers want, and what luxury brands must now deliver. Not louder claims. Not flashier ...

As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor ...

Waksal, who is not a medical doctor, imported the veterinary drug along with other “unapproved ingredients” from Colombia.

Perhaps no industry is as reliant on grant-funded university research as is bioscience, the companies that develop ...

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...

In the heart of Austin, where music and innovation often intersect, beloved local Casey McPherson’s story has struck a chord ...